However, because UP has numerous potential pruritogens, such as toxins, Th1 cells, and peripheral neuropathy (18), and because dupilumab only targets IL-4Rα, its antipruritic effect on UP remains to be observed, and the sample size needs to be expanded. Here, IL4R is linked to peripheral neuropathy.